Drug Shortage Report for JAMP DESVENLAFAXINE

Last updated on 2024-03-12 History
Report ID 192208
Drug Identification Number 02495147
Brand name JAMP DESVENLAFAXINE
Common or Proper name Desvenlafaxine Extended Release Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) DESVENLAFAXINE
Strength(s) 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 90
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-05-10
Estimated end date 2024-05-31
Actual end date
Shortage status Actual shortage
Updated date 2024-03-12
Company comments Increase in demand. Under allocation.
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2024-03-12 French Compare
v13 2024-03-12 English Compare
v12 2023-11-28 French Compare
v11 2023-11-28 English Compare
v10 2023-09-26 French Compare
v9 2023-09-26 English Compare
v8 2023-09-11 French Compare
v7 2023-09-11 English Compare
v6 2023-08-25 French Compare
v5 2023-08-25 English Compare
v4 2023-08-08 French Compare
v3 2023-08-08 English Compare
v2 2023-05-11 French Compare
v1 2023-05-11 English Compare

Showing 1 to 14 of 14